ViroMag Transduction Reagent is a magnetic nanoparticles formulation dedicated to increase virus infection and transduction capacities; it is suitable for all viruses. Based on the Magnetofection? technology, this reagent allows concentrating the complete applied dose of viral particles onto cells within minutes, inducing a significant improvement of virus transduction with extremely low vector doses. Due to its specific properties, ViroMag is ideal to infect non permissive cells. This reagent demonstrates an exceptionally high efficiency to promote, control and assist viral transductions so that no molecular biology processes or biochemical modifications are required.

?

Increases transduction efficiency

Accelerates the transduction process

Efficient for hard-to-infect and non-permissive cells

Concentrates the viral dose onto the cells

Suitable for all type of virus

Synchronise cells adsorption/infection without modifications of the viruses

?

ViroMag transduction reagent:

Sizes:

100 μL: 30-500 transductions in 96-well plate

200 μL: 60-1000 transductions in 96-well plate

1 mL: 300-5000 transductions in 96-well plate

#KC30500: ViroMag Starting Kit with Super Magnetic plate + 200 μL of ViroMag

#KC30600: ViroMag Triple Starting Kit with Super Magnetic plate + 100 μL of ViroMag, AdenoMag, ViroMag RL

?

艾美捷OZ Biosciences?ViroMag轉(zhuǎn)導試劑#VM40100是一種磁性納米顆粒配方，致力于提高病毒感染和轉(zhuǎn)導能力;它適用于所有病毒?；诖鸥袘? 技術(shù)上，該試劑允許在幾分鐘內(nèi)將病毒顆粒的完整施用劑量濃縮到細胞上，從而以極低的載體劑量顯著改善病毒轉(zhuǎn)導。由于其特殊特性，ViroMag是感染非許可細胞的理想選擇。該試劑在促進、控制和輔助病毒轉(zhuǎn)導方面表現(xiàn)出極高的效率，因此不需要分子生物學過程或生化修飾。

?

ViroMag轉(zhuǎn)導試劑特色：

提高轉(zhuǎn)導效率

加速轉(zhuǎn)導過程

對難以感染和非允許的細胞有效

將病毒劑量集中在細胞上

適用于所有類型的病毒

同步細胞吸附/感染，無需修飾病毒

?

病毒轉(zhuǎn)導試劑：

規(guī)格：

100 μL：在 30 孔板中進行 500-96 次轉(zhuǎn)導

200 μL：在 60 孔板中進行 1000-96 次轉(zhuǎn)導

1 mL：300 孔板中的 5000-96 次轉(zhuǎn)導

#KC30500：ViroMag 起始套件，帶超級磁性板 + 200 μL ViroMag

#KC30600：ViroMag 三重啟動套件超級磁板+ 100 μL 病毒鎂，腺磁,維羅馬格 RL

儲存：?+4°C

運輸條件：室溫

?

OZ Biosciences?VIROMAG 100磁轉(zhuǎn)導試劑結(jié)果：

圖1：病毒增強腺病毒感染。K562，PBL和NIH-3T3細胞單獨感染腺病毒（Ad-LacZ）或腺病毒復合物和3 μL病毒。細胞是否屈服于磁場，感染后24H測定β-半乳糖苷酶表達。

圖2：HIV感染或不感染病毒的時間過程